Cambridge Investment Research Advisors Inc. lifted its stake in shares of AdvanSix Inc. (NYSE:ASIX – Get Rating) by 5.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 8,806 shares of the company’s stock after acquiring an additional 478 shares during the quarter. Cambridge Investment Research Advisors Inc.’s holdings in AdvanSix were worth $283,000 at the end of the most recent reporting period.
A number of other hedge funds have also made changes to their positions in the stock. Royal Bank of Canada increased its stake in shares of AdvanSix by 1.6% during the first quarter. Royal Bank of Canada now owns 21,850 shares of the company’s stock valued at $1,116,000 after acquiring an additional 350 shares during the period. Texas Permanent School Fund increased its stake in shares of AdvanSix by 1.9% during the second quarter. Texas Permanent School Fund now owns 20,316 shares of the company’s stock valued at $679,000 after acquiring an additional 372 shares during the period. Diversified Trust Co grew its position in AdvanSix by 6.5% in the third quarter. Diversified Trust Co now owns 8,452 shares of the company’s stock worth $271,000 after buying an additional 519 shares during the last quarter. Federated Hermes Inc. grew its position in AdvanSix by 4.6% in the second quarter. Federated Hermes Inc. now owns 12,241 shares of the company’s stock worth $409,000 after buying an additional 537 shares during the last quarter. Finally, Yousif Capital Management LLC grew its position in AdvanSix by 2.2% in the first quarter. Yousif Capital Management LLC now owns 26,597 shares of the company’s stock worth $1,359,000 after buying an additional 585 shares during the last quarter. Institutional investors and hedge funds own 83.67% of the company’s stock.
Wall Street Analyst Weigh In
Several research firms have issued reports on ASIX. Piper Sandler set a $52.00 price target on shares of AdvanSix in a research report on Wednesday, November 23rd. StockNews.com upgraded shares of AdvanSix from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, November 16th.
Insider Buying and Selling
AdvanSix Trading Up 0.2 %
AdvanSix stock opened at $43.17 on Friday. The company has a 50 day moving average price of $39.57 and a 200 day moving average price of $36.85. AdvanSix Inc. has a 52 week low of $30.69 and a 52 week high of $57.10. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.68 and a current ratio of 1.14. The firm has a market capitalization of $1.19 billion, a price-to-earnings ratio of 7.81 and a beta of 1.79.
AdvanSix (NYSE:ASIX – Get Rating) last posted its quarterly earnings data on Friday, November 4th. The company reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.22 by $0.15. AdvanSix had a net margin of 8.23% and a return on equity of 24.18%. The firm had revenue of $478.77 million during the quarter, compared to analyst estimates of $463.47 million. Research analysts forecast that AdvanSix Inc. will post 6.39 EPS for the current year.
AdvanSix Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, November 29th. Investors of record on Tuesday, November 15th were paid a $0.145 dividend. This represents a $0.58 dividend on an annualized basis and a yield of 1.34%. The ex-dividend date was Monday, November 14th. AdvanSix’s dividend payout ratio is 10.49%.
AdvanSix Inc manufactures and sells polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, alpha-methyl styrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.
- Get a free copy of the StockNews.com research report on AdvanSix (ASIX)
- MarketBeat: Week in Review 01/09-01/13
- JPMorgan Chase Falls As Banks Brace For Recession
- Why is the Bed Bath & Beyond Stock Price up 261%?
- Roku Stock Price is Trending, Here’s Why
- Carvana Stock Rally, Here’s What You Need to Know
Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.